Risk Evaluation in Pharmaceutical Fill/Finish Sourcing
Tips for Risk Evaluation in Pharmaceutical Fill/Finish Sourcing In this post we focus on the critical decision pharmaceutical companies face regarding their fill/finish needs: whether
We manufacture your pharmaceutical, life science, and in-vitro diagnostic (IVD) products with quality, innovation and efficiency as if they were our own.
Only when you reach your goals do we reach ours.
No other life science, diagnostic, or drug product contract manufacturing organization (CMO) offers broader scale, more flexibility and faster speed to market with lower risk, and less capital expenditures.
~Wayne Woodard, CEO
Argonaut is your CMO for Aseptic Fill & Finish, In-Vitro Diagnostics (IVD) and Life Science products:
Transform your operations team into a competitive advantage and accelerate your innovation engine. Here are just a few reasons to outsource manufacturing:
Core Competencies
Tips for Risk Evaluation in Pharmaceutical Fill/Finish Sourcing In this post we focus on the critical decision pharmaceutical companies face regarding their fill/finish needs: whether
In Part 1 of this two-part series we highlighted the characterization and functions of LyoDots® and now in Part 2 we uncover specific LyoDots benefits
LyoDots® are a unique miniaturized format of lyophilized reagent that can revolutionize diagnostic device development. In this two-part series we explore how instrument and assay
Sign up to receive our newsletter & get instant access to the free Case Studies of your choice.